Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are anticipating strong growth driven by the robust sales of tirzepatide supplier near you. for tirzepatide dosage Lilly's blockbuster treatments, particularly its insulin portfolio. However, there are al